Changes in Preventive Medical Therapies and CV Risk Factors After CT Angiography

Objectives The aim of the study was to determine the association of coronary computed tomographic angiography (CTA)–identified coronary artery disease (CAD) with post-test aspirin, statin, and antihypertensive medication use and changes in cholesterol and blood pressure (BP). Background The relation...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JACC. Cardiovascular imaging 2013-05, Vol.6 (5), p.574-581
Hauptverfasser:	Cheezum, Michael K., MD, Hulten, Edward A., MD, MPH, Smith, Ryan M., DO, Taylor, Allen J., MD, Kircher, Jacqueline, MD, Surry, Luke, MD, York, Matthew, Villines, Todd C., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antihypertensive Agents - therapeutic use Aspirin - therapeutic use Biomarkers - blood Blood Pressure - drug effects Cardiovascular Chi-Square Distribution Cholesterol - blood Coronary Angiography - methods Coronary Artery Disease - blood Coronary Artery Disease - diagnostic imaging Coronary Artery Disease - physiopathology Coronary Artery Disease - therapy Decision Support Techniques Female Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Linear Models Logistic Models Male Middle Aged Multivariate Analysis Odds Ratio Platelet Aggregation Inhibitors - therapeutic use Practice Patterns, Physicians Predictive Value of Tests Preventive Health Services Retrospective Studies Risk Assessment Risk Factors Severity of Illness Index Tomography, X-Ray Computed Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Objectives The aim of the study was to determine the association of coronary computed tomographic angiography (CTA)–identified coronary artery disease (CAD) with post-test aspirin, statin, and antihypertensive medication use and changes in cholesterol and blood pressure (BP). Background The relationship of CTA findings to subsequent changes in preventive cardiovascular medication prescribing patterns and risk factors is largely unknown. Methods We studied 1,125 consecutive patients without known CAD referred for coronary CTA. CAD was defined as none, nonobstructive (
ISSN:	1936-878X 1876-7591
DOI:	10.1016/j.jcmg.2012.11.016